Literature DB >> 1330435

Recruiting children and their families for clinical trials: a case study.

W M Vollmer1, S Hertert, M J Allison.   

Abstract

We describe the recruitment of 226 families for participation in a randomized trial examining the effectiveness of alternative strategies for the management of pediatric asthma. All families were members of a large health maintenance organization. Families of children identified through emergency room and hospital admission records were much more likely to participate in the study than were families of children identified only through outpatient prescription records. Specific details of the recruitment process are described.

Entities:  

Mesh:

Year:  1992        PMID: 1330435     DOI: 10.1016/0197-2456(92)90013-p

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  4 in total

1.  Challenges and successes of recruitment in the "angiotensin-converting enzyme inhibition in infants with single ventricle trial" of the Pediatric Heart Network.

Authors:  Nancy A Pike; Victoria Pemberton; Kerstin Allen; Jeffrey P Jacobs; Daphne T Hsu; Alan B Lewis; Nancy Ghanayem; Linda Lambert; Kari Crawford; Teresa Atz; Rosalind Korsin; Mingfen Xu; Chitra Ravishankar; James Cnota; Gail D Pearson
Journal:  Cardiol Young       Date:  2012-07-05       Impact factor: 1.093

2.  Recruitment and retention of physicians for primary care research.

Authors:  Brent J Shelton; James L Wofford; Carol A Gosselink; Maureen W McClatchey; Karen Brekke; Colleen Conry; Pamela Wolfe; Stuart J Cohen
Journal:  J Community Health       Date:  2002-04

3.  Grassroots campaign trail methods to recruit for clinical trials: recruitment lessons learned from trail to trial.

Authors:  Megan Murphy; Daniel Merenstein
Journal:  Clin Med Insights Pediatr       Date:  2011-02-23

4.  Developing a survey of barriers and facilitators to recruitment in randomized controlled trials.

Authors:  Geetinder Kaur; Rosalind L Smyth; Paula Williamson
Journal:  Trials       Date:  2012-11-21       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.